|
(1) Scoazec JY. C-Kit
et tumeurs « stromales » gastrointestinales:
plus qu ’un nouveau marqueur. Ann Pathol 2000,
20, 1: 91-92
(2) Ray-coquard I et al. Tumeurs
stromales du tractus digestif: actualité 2003.
Bull Cancer2003; 90(1): 69-76
(3) Miettinen M et al. Gastrointestinal
stromal tumors- definition, occurence, pathology, differential
diagnosis and molecular genetics. Pol J Pathol 2003;
54,1: 3-24
(4) Scoazec JY. C-kit:
une irresistible ascension, du statut de marqueur diagnostique
à celui de cible thérapeutique. Ann Pathol
2002; 22: 173-5
(5) Duffaud F et al. Gastrointestinal
Stromal Tumors: bilogy and treatment. Oncology 2003;65:
187-195
(6) Heinrich M. et al. Kinase
mutations and imatinib response in patients with metastatic
gastrointestinal stromal tumor. J. Clin. Oncol. 2003;
21(33): 4342-4349
(7) Hirota S. et al. Gain
of function mutations of Platelet Derived Growth factor
receptor A gene in GIST. Gastroenterol. 2003; 125: 660-667
(8) Balaton et al. Gastrointestinal
stromal tumors. Gastroenterol Clin Biol. 2001 May;25(5):473-82
(9) Fletcher CDM et al. Diagnosis
of Gastrointestinal Stromal Tumors: A consensus Approach.
Human pathology 2002; 33, 5: 459- 465
|
